ArriVent BioPharma, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for ArriVent BioPharma, Inc. (AVBP) is 1.34B

According to ArriVent BioPharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.34B. This represents a change of 77.35% compared to the average of 754.12M of the last 4 quarters.

ArriVent BioPharma, Inc. (AVBP) Historical Enterprise Value (quarterly & annually)

How has AVBP Enterprise Value performed in the past?

The mean historical Enterprise Value of ArriVent BioPharma, Inc. over the last ten years is 495.30M. The current 1.34B Enterprise Value has changed 26.90% with respect to the historical average. Over the past ten years (40 quarters), AVBP's Enterprise Value was at its highest in in the March 2026 quarter at 978.03M. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.

ArriVent BioPharma, Inc. (AVBP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ArriVent BioPharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ArriVent BioPharma, Inc. (AVBP) Average Enterprise Value

How has AVBP Enterprise Value performed in the past?

The current Enterprise Value of ArriVent BioPharma, Inc. (AVBP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ArriVent BioPharma, Inc. (AVBP) Enterprise Value vs. Peers

How is AVBP’s Enterprise Value compared to its peers?

ArriVent BioPharma, Inc.’s Enterprise Value is greater than MeiraGTx Holdings plc (1.09B), greater than Replimune Group, Inc. (356.71M), greater than Astria Therapeutics, Inc. (626.31M), less than MBX Biosciences, Inc. Common Stock (3.00B), greater than Ginkgo Bioworks Holdings, Inc. (764.61M), less than Iovance Biotherapeutics, Inc. (1.89B), greater than Valneva SE (522.41M), less than Erasca, Inc. (6.15B), greater than Arvinas, Inc. (451.66M), less than Day One Biopharmaceuticals, Inc. (2.03B),

Build a custom stock screener for ArriVent BioPharma, Inc. (AVBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ArriVent BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ArriVent BioPharma, Inc. (AVBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ArriVent BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.